CD8A and COVID-19: In severe COVID-19 patients with ARDS an increased ratio of MDSC to CD8 effector memory T cell was observed compared to patients hospitalized for COVID-19 moderate pneumonia, with COVID-19-related MDSC expansion directly correlating with lymphopenia and enhanced arginase activity (51).